跳至主要内容
临床试验/NCT04190602
NCT04190602招募中不适用

The AcChord Study: A Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System

NeoChord5 个研究点 分布在 3 个国家目标入组 500 人开始时间: 2020年2月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
5
主要终点
Level of Mitral Regurgitation Following the Index Procedure

研究概览

简要总结

The objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.

详细描述

This study is an observational, single-arm, multicenter post-market registry. Both prospective and retrospective enrollment will be allowed. No additional invasive or burdensome examinations outside those routinely required for the standard mitral valve repair procedure will be requested.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has Grade III Moderate or Grade IV Severe degenerative or mixed disease mitral valve regurgitation
  • Study procedure completed after 31 December 2016

排除标准

  • Heavily calcified valves
  • Valvular retraction with severely reduced mobility
  • Active bacterial endocarditis
  • Complex mechanism of MR (leaflet perforation, etc.)
  • Significant tethering of leaflets
  • Inflammatory valve disease

结局指标

主要结局

Level of Mitral Regurgitation Following the Index Procedure

时间窗: Completion of Index Procedure

Level of mitral regurgitation per echocardiography

次要结局

  • Level of Mitral Regurgitation at 5 Years(5 Years)
  • Level of Mitral Regurgitation at 3-6 Months(3-6 Months)
  • Level of Mitral Regurgitation at 1 Year(1 Year)
  • Level of Mitral Regurgitation at 2 Years(2 Years)
  • Level of Mitral Regurgitation at 3 Years(3 Years)
  • Level of Mitral Regurgitation at 4 Years(4 Years)

研究者

发起方
NeoChord
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验